Literature DB >> 27533905

Decellularized extracellular matrix repair of volumetric muscle loss injury impairs adjacent bone healing in a rat model of complex musculoskeletal trauma.

Beth E Pollot1, Stephen M Goldman, Joseph C Wenke, Benjamin T Corona.   

Abstract

BACKGROUND: Traumatic muscle loss (i.e., volumetric muscle loss [VML] injury) impairs adjacent fracture healing but is often left untreated. A promising therapy for this application is a decellularized extracellular matrix (ECM) because of their capacity to regenerate a vascularized tissue bed. This study tested the hypothesis that repair of VML concomitant to fracture with a small intestine submucosa (SIS)-ECM improves musculoskeletal healing.
METHODS: In male Lewis rats (~375 g), a 3-mm segmental bone defect (SBD) was created in concomitance with a 6-mm, full-thickness VML injury to the adjacent tibialis anterior (TA) muscle. For all rats (n = 10), the SBD was treated with internal plate fixation and delivery of recombinant human bone morphogenetic protein 2 (1 μg) on a collagen sponge. The VML either had no repair or SIS-ECM repair (n = 5/group). Bone regeneration within the SBD (BV/TV [bone volume as a fraction of total volume]) was assessed via in vivo micro-computed tomography at 2, 4, and 6 weeks and histology at 6 weeks after injury. Tibialis anterior muscle in vivo strength and histologic assessments were performed at 6 weeks after injury.
RESULTS: Compared with no repair, SIS-ECM presented -21% (p = 0.09) and -27% (p = 0.004) BV/TV at 4 and 6 weeks after injury, respectively. At 6 weeks, the SBD gap length was shorter for the no repair than that for the SIS-ECM (2.64 ± 0.30 and 3.67 ± 0.41 mm, respectively; p = 0.09), whereas the distances from the end of each cortical segment to the center of the first stabilization screw were longer (1.86 ± 0.25 and 0.85 ± 0.30 mm, respectively; p = 0.035), indicating enhanced resorption in the SIS-ECM group. Both groups presented similar magnitude TA muscle strength deficits compared with their contralateral limbs (10-150 Hz: no repair, -58% to 67%; SIS-ECM, -51% to 74%). The TA muscle of the SIS-ECM group was remarkable for its presentation of fibrosis, edema, and immune cell presence.
CONCLUSIONS: Small intestine submucosa-ECM VML repair impaired open fracture healing and failed to improve skeletal muscle strength.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27533905     DOI: 10.1097/TA.0000000000001212

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  10 in total

1.  Preclinical Development of Bioengineered Allografts Derived from Decellularized Human Diaphragm.

Authors:  Silvia Barbon; Elena Stocco; Martina Contran; Federico Facchin; Rafael Boscolo-Berto; Silvia Todros; Deborah Sandrin; Filippo Romanato; Piero Pavan; Veronica Macchi; Vincenzo Vindigni; Franco Bassetto; Raffaele De Caro; Andrea Porzionato
Journal:  Biomedicines       Date:  2022-03-22

2.  Autologous minced muscle grafts improve endogenous fracture healing and muscle strength after musculoskeletal trauma.

Authors:  Brady J Hurtgen; Catherine L Ward; Chrissy M Leopold Wager; Koyal Garg; Stephen M Goldman; Beth E P Henderson; Todd O McKinley; Sarah M Greising; Joseph C Wenke; Benjamin T Corona
Journal:  Physiol Rep       Date:  2017-07

3.  Tacrolimus as an adjunct to autologous minced muscle grafts for the repair of a volumetric muscle loss injury.

Authors:  Benjamin T Corona; Jessica C Rivera; Joseph C Wenke; Sarah M Greising
Journal:  J Exp Orthop       Date:  2017-11-10

4.  Co-delivery of a laminin-111 supplemented hyaluronic acid based hydrogel with minced muscle graft in the treatment of volumetric muscle loss injury.

Authors:  Stephen M Goldman; Beth E P Henderson; Thomas J Walters; Benjamin T Corona
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

5.  Impairment of early fracture healing by skeletal muscle trauma is restored by FK506.

Authors:  Brady J Hurtgen; Beth E P Henderson; Catherine L Ward; Stephen M Goldman; Koyal Garg; Todd O McKinley; Sarah M Greising; Joseph C Wenke; Benjamin T Corona
Journal:  BMC Musculoskelet Disord       Date:  2017-06-12       Impact factor: 2.362

6.  Synthetic matrix enhances transplanted satellite cell engraftment in dystrophic and aged skeletal muscle with comorbid trauma.

Authors:  Woojin M Han; Shannon E Anderson; Mahir Mohiuddin; Daniela Barros; Shadi A Nakhai; Eunjung Shin; Isabel Freitas Amaral; Ana Paula Pêgo; Andrés J García; Young C Jang
Journal:  Sci Adv       Date:  2018-08-15       Impact factor: 14.136

7.  Biomimetic sponges improve functional muscle recovery following composite trauma.

Authors:  Andrew Dunn; Gabriel Haas; Joshua Madsen; Natalia Ziemkiewicz; Jeffrey Au; David Johnson; Charles West; Hannah Chauvin; Sara McBride Gagyi; Koyal Garg
Journal:  J Orthop Res       Date:  2021-08-17       Impact factor: 3.102

8.  Inflammatory and Physiological Consequences of Debridement of Fibrous Tissue after Volumetric Muscle Loss Injury.

Authors:  Benjamin T Corona; Jessica C Rivera; Sarah M Greising
Journal:  Clin Transl Sci       Date:  2017-11-28       Impact factor: 4.689

9.  New Surgical Model for Bone-Muscle Injury Reveals Age and Gender-Related Healing Patterns in the 5 Lipoxygenase (5LO) Knockout Mouse.

Authors:  Claudia Cristina Biguetti; Maira Cristina Rondina Couto; Ana Claudia Rodrigues Silva; João Vitor Tadashi Cosin Shindo; Vinicius Mateus Rosa; André Luis Shinohara; Jesus Carlos Andreo; Marco Antonio Hungaro Duarte; Zhiying Wang; Marco Brotto; Mariza Akemi Matsumoto
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

Review 10.  An overview of advanced biocompatible and biomimetic materials for creation of replacement structures in the musculoskeletal systems: focusing on cartilage tissue engineering.

Authors:  Azizeh Rahmani Del Bakhshayesh; Nahideh Asadi; Alireza Alihemmati; Hamid Tayefi Nasrabadi; Azadeh Montaseri; Soodabeh Davaran; Sepideh Saghati; Abolfazl Akbarzadeh; Ali Abedelahi
Journal:  J Biol Eng       Date:  2019-11-13       Impact factor: 4.355

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.